Drug intelligence / Profile preview

cyclocarya paliurus ethanol extract

Development stage
Preclinical
Lead developer
Wenzhou Medical University
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Cyclocarya paliurus ethanol extract (CPEE), also referred to as ECL, is a botanical extract derived from the leaves of *Cyclocarya paliurus* (Batal.) Iljinsk, a tree native to southern China. Traditionally used as an herbal tea in Chinese folk medicine for centuries, it is employed to treat hyperglycemia, hyperlipidemia, and obesity. In modern preclinical research, CPEE is investigated for its potential therapeutic effects on glucolipid metabolism, non-alcoholic fatty liver disease (NAFLD), and diabetic cardiomyopathy. The extract's mechanism of action involves the modulation of the PI3K/Akt/NF-κB signaling pathway, which mediates anti-inflammatory, antifibrotic, and antiapoptotic activities. Additionally, it has been shown to promote lipophagy, thereby reducing hepatic lipid deposition. CPEE is primarily studied by academic institutions in China, including Wenzhou Medical University, Beijing University of Chinese Medicine, and Peking Union Medical College.

Other names
Cyclocarya paliurus extractSweet Tea Tree extract
02

Targets

NF-κBAKT (RAC-alpha serine/threonine-protein kinase)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)

Beyond the preview

Go deeper on cyclocarya paliurus ethanol extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cyclocarya paliurus ethanol extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call